Observational Study on the Qualification and Indication of Endoscopic Gastroesophageal Anti-Reflux Mucosal Resection Technique for Patients with Refractory Gastroesophageal Reflux Disease

Observational Study on the Qualification and Indication of Endoscopic Gastroesophageal Anti-Reflux Mucosal Resection Technique for Patients with Refractory Gastroesophageal Reflux Disease - Prospective Observational Study on Endoscopic Gastroesophageal Reflux Prevention

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051308

Enrollment

150

Registered

2023-06-09

Start date

2023-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease (GERD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients scheduled for endoscopic treatment for GERD

Exclusion criteria

Exclusion criteria: Study subjects deemed inappropriate by the principal investigator or physician in charge (cases who failed to complete GERD endoscopic treatment are not excluded from enrollment).

Design outcomes

Primary

Measure	Time frame
Patients will be divided into effective and ineffective endoscopic treatment groups and compared on preoperative background factors and intraoperative findings.	—

Countries

Japan

Contacts

Public ContactKazuhiro Ota

Osaka Medical and Pharmaceutical University Hospital Endoscopy Center

kazuhiro.ota@ompu.ac.jp072-683-1221

Outcome results